1
2
3

Information List

Xi Jinping: Accelerate the in-depth development of military-civilian integration

2018-10-25

China Government Network 2018-10-15 Source: Xinhua News Agency Xi Jinping presided over the second meeting of the Central Military-civilian Integration Development Committee, emphasizing the strengthening of responsibility, implementation, and accelerating the in-depth development of military-civilian integration. Wang Huning and Han Zheng attended the General Secretary of the CPC Central Committee, President of the State, Chairman of the Central Military Commission, and Director of the Central Military-civilian Integration Development Committee Xi Jinping presided over the second meeting of the Central Military-civilian Integration Development Committee on October 15th and delivered an important speech. The meeting considered and adopted the opinions on strengthening the construction of the rule of law in the development of military and civilian integration. Xi Jinping stressed that we should strengthen responsibility, pay close attention to implementation and improve the rule of law.

The State Council Releases "Double Creation" Upgrade Opinions: Supporting the Listing of Innovative Enterprises That have Not Yet Profitable

2018-10-25

Abstract: when the reform of the Association for Science and Technology is in progress, it was reported on September 26, 2018 that the State Council's opinions on promoting the high-quality development of innovation and entrepreneurship and creating an upgraded version of "mass entrepreneurship and innovation" (Guofa [2018] No. 32), including increasing support for "specialized, special and new" small and medium-sized enterprises, encouraging small and medium-sized enterprises to participate in the research and development of key common technologies in the industry, continuously improving the innovation ability of enterprises, and cultivate innovative ability, support innovative enterprises with good development potential but not yet profitable to be listed or listed on the new three boards and regional equity markets. Technology companies are allowed to implement a "same share with different rights" governance structure, and so on. Tools

Draft for Soliciting Comments on the People's Republic of China Atomic Energy Law

2018-10-25

Abstract: Xinhua News Agency, Beijing, September 21, 2018. The Ministry of Justice announced the "the People's Republic of China Atomic Energy Law (Draft for Comment)" on the 21st to solicit public opinions. These include: strengthening the scientific research and technology development of atomic energy, promoting the construction of professional talents in the field of atomic energy, promoting technological innovation, realizing the development of military-civilian integration, encouraging and supporting enterprises to participate in the development of the international market, and promoting exports. For details, please refer to the original draft of the the People's Republic of China Atomic Energy Law.

Wuxi Beta and Shenyang Research Institute of Chemical Industry to establish a cooperative relationship

2018-10-25

On August 15, 2018, Wuxi Beta Pharmaceutical Technology Co., Ltd. and the Safety Evaluation Center of Shenyang Research Institute of Chemical Industry signed a strategic cooperation agreement to complement each other's advantages and do their best to cooperate in the development of C14 and tritium labeling of pesticides and the pharmaceutical generation of animals and plants in China Research, actively promote China's agricultural development and environmental protection.

Wuxi Beta establishes partnership with American CIL

2018-10-25

On July 18, 2018, Wuxi Beta Pharmaceutical Technology Co., Ltd. signed a supply agreement with CambridgeIsotopeLaboratories,Inc.(CIL) to jointly develop the industrialization of isotope labeled products such as urea-13C and promote the popularization of gastric Helicobacter pylori detection in China.

Gradually realize import substitution, in vitro diagnostics industry to open a market of hundreds of billions.

2018-10-25

Translational Medicine Network 2018-06-08 Today, our "Looking for Real Growth in the Pharmaceutical Industry" series focuses on medical devices. Its largest subdivision is in vitro diagnosis. In vitro diagnosis refers to the extraction of patients' blood for testing and guiding treatment. At present, more than 70% of clinical diagnostic information comes from in vitro diagnosis, so it is also called "doctor's eyes". Let's take a look at the reporter survey. The import of medical devices relies heavily on multinational companies to monopolize the market. The West China Hospital of Sichuan University in Chengdu has to process about 18000 test specimens from all over the country every day. in the busy

Academician Li Zhaoshen Calls for Gastric Cancer Screening to Rise to National Plan (PG, G-17, Hp Concerned)

2018-10-25

In Vitro Diagnostic Network April 17, 2018 Reducing the incidence and mortality of gastric cancer in my country has always been an important issue to be resolved in the field of public health. Recently, China's early gastric cancer screening process expert consensus (draft) published, the consensus to further refine the "China early gastric cancer screening and endoscopic diagnosis and treatment consensus (2014, Changsha)" and establish suitable for China's national conditions of early gastric cancer screening process. Li Zhaoshen: Call for gastric cancer screening to rise to the national plan to "eliminate" the only way for advanced cancer. Academician Li Zhaoshen said that corresponding to the high incidence of digestive tract tumors, China

Research Status of Radioisotope Carbon -14 Labeled Synthesis in China

2021-02-25

National Science and Technology Progress Award: Eradication of Helicobacter pylori, effective prevention of gastric cancer

2018-10-25

Source: Dr. Cheng on Digestion 2018-01-19 Author: Dr. Cheng Hong On January 8, 2017, the 2017 National Science and Technology Awards Conference was held ceremoniously in the Great Hall of the People in Beijing. Peking University medical three outstanding science and technology successfully won the second prize of the National Science and Technology Progress Award. In the achievements of "the creation and application of key technologies of comprehensive prevention and control system of gastric cancer" with Professor Ji Jiafu of Peking University Cancer Hospital as the first person, the feasible strategy of gastric cancer prevention and control was pioneered in the world to effectively reduce the risk of gastric cancer. It is the first and currently the only prospective randomized controlled intervention study in the world.

Wuxi Beta establishes cooperative relationship with China Academy of Engineering Physics

2018-10-25

On January 31, 2018, Wuxi Beta Pharmaceutical Technology Co., Ltd. and the Second Institute of China Academy of Engineering Physics signed a memorandum of cooperation to cooperate in the development of my country's C14 source materials and tracer technology, promote military-civilian integration, and nuclear technology in the medical and medical fields Application to benefit human health.

< 1234567 >